pharmaceuticals

Aarti Industries Ltd (AARTIIND) Q2 FY23 Earnings Concall Transcript

● Nov 15, 2022

Aarti Industries Ltd (NSE:AARTIIND) Q2 FY23 Earnings Concall dated Nov. 15, 2022 Corporate Participants: Rajendra V. Gogri — Chairman and...

JB Chemicals & Pharmaceuticals Limited (JBCHEPHARM) Q2 FY23 Earnings Concall Transcript

● Nov 14, 2022

JB Chemicals & Pharmaceuticals Limited (NSE:JBCHEPHARM) Q2 FY23 Earnings Concall dated Nov. 14, 2022 Corporate Participants: Jason D’Souza — Vice President of Investor Relations...

Aurobindo Pharma Limited (AUROPHARMA) Q2 FY23 Earnings Concall Transcript

● Nov 13, 2022

Aurobindo Pharma Limited (NSE: AUROPHARMA) Q2 FY23 Earnings Concall dated Nov. 13, 2022 Corporate Participants: Deepti Thakur — Investor Relations Santhanam Subramanian — Chief...

Gufic Biosciences Limited (GUFICBIO) Q1 FY23 Earnings Concall

● Nov 13, 2022

Gufic Biosciences Limited (NSE:GUFICBIO) Q2 FY23 Earnings Concall dated Nov.13, 2022 Corporate Participants: Ami Naresh Shah — Company Secretary and Compliance Officer...

Alkem Laboratories Ltd (ALKEM) Q2 FY23 Earnings Concall Transcript

● Nov 11, 2022

Alkem Laboratories Ltd (NSE:ALKEM) Q2 FY23 Earnings Concall dated Nov. 11, 2022 Corporate Participants: Amit Kumar Khandelia — Assistant Vice...

Supriya Lifescience Ltd (SUPRIYA) Q2 FY23 Earnings Concall Transcript

● Nov 11, 2022

Supriya Lifescience Ltd (NSE:SUPRIYA) Q2 FY23 Earnings Concall dated Nov. 11, 2022 Corporate Participants: Rasika Sawant — Investor Relation Partner...

NATCO Pharma Limited (NATCOPHARM) Q2 FY22 Earnings Concall Transcript

● Nov 11, 2022

NATCO Pharma Limited (NSE:NATCOPHARM) Q2 FY22 Earnings Concall dated Nov. 11, 2022 Corporate Participants: Rajeev Nannapaneni — Director and Chief Executive Officer...

Sequent Scientific Limited Q2 FY23 Earnings Conference Call Insights

● Nov 11, 2022

Key highlights from Sequent Scientific Limited (SEQUENT) Q2 FY23 Earnings Concall Q&A Highlights: [00:17:40] Rishab Jain asked about Tineta Pharma...

Dr Lal PathLabs Ltd Q2 FY23 Earnings Conference Call Insights

● Nov 10, 2022

Key highlights from Dr Lal PathLabs Ltd (LALPATHLAB) Q2 FY23 Earnings Concall Q&A Highlights: [00:16:43] Rahul Agarwal with Incred Capital...

Lupin Q2FY23 results out: Net profit rises more than 100%

● Nov 10, 2022

Shares of Lupin gained as much as 8 percent in early trading on Thursday after the company returned to profitability...